Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Detemir vs Exenatide vs Combination in T2DM
NCT01076842Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2008
- Primary completion
- Apr 2011
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin detemir, exenatide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Apr 2008; status: completed.
02
Drugs
insulin detemirexenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01076842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01076842.